First Meeting of Avon Foundation Breast Cancer Prevention Research
Initiative Taking Place July 10-11 in San Francisco
SAN FRANCISCO, July 9 /PRNewswire/ -- Leading breast cancer researchers from across the country are convening in San Francisco July 10-11 for the first meeting of the Avon Foundation Breast Cancer Prevention Research Initiative. The two-day meeting, taking place at the Westin St. Francis, brings together researchers from leading institutions who are focused on the remarkable research in breast cancer biomarkers that has taken place over the last three years. The goal is to use the latest biomarker knowledge to develop new tests for the earliest detection and diagnostics in breast cancer -- ultimately leading to monitor the earliest changes in healthy breasts before cancer occurs.
Current breast cancer screening relies primarily on imaging, including mammography, ultrasound and MRI. While these diagnostic modalities provide the opportunity for detection and successful treatment, the aim of the new Avon Foundation-funded research initiative is to pursue non-imaging techniques that offer compelling and innovative opportunities. In support of this novel direction, 12 projects were selected through a competitive application process, with a total of $7.6 million awarded in support of their research. The projects, which are focused on fairly simple but effective methods, range from developing a new "band-aid" dipstick that collects fluid from nipple discharge to several projects that attempt to measure markers in blood to detect the very earliest breast cancer development.
The leaders of the research projects are meeting to present preliminary findings and share ideas in a spirit of collaboration and a shared commitment to ending breast cancer. Included is one pharmaceutical company, A&G Pharmaceutical, in addition to the individual medical researchers.
"The Avon Foundation is proud to support these researc
|SOURCE Avon Foundation|
Copyright©2008 PR Newswire.
All rights reserved